Novel Approaches to Exploiting Invariant NKT Cells in Cancer Immunotherapy

by Benjamin J. Wolf, Jiyoung Elizabeth Choi, Jiyoung Elizabeth Choi, Mark A. Exley, Mark A. Exley, Mark A. Exley
Published 2018-03-01

Positive & Negative Roles of Innate Effector Cells in Controlling Cancer Progression

by Dorian Stolk, Hans J. van der Vliet, Tanja D. de Gruijl, Yvette van Kooyk, Mark A. Exley, Mark A. Exley, Mark A. Exley
Published 2018-09-01

Paucity of CD4+ natural killer T (NKT) lymphocytes in sooty mangabeys is associated with lack of NKT cell depletion after SIV infection.

by Namita Rout, James G Else, Simon Yue, Michelle Connole, Mark A Exley, Amitinder Kaur
Published 2010-03-01

Defective NKT cell activation by CD1d+ TRAMP prostate tumor cells is corrected by interleukin-12 with α-galactosylceramide.

by Michael Nowak, Mohammed S Arredouani, Adrian Tun-Kyi, Ingo Schmidt-Wolf, Martin G Sanda, Steven P Balk, Mark A Exley
Published 2010-06-01

Loss of effector and anti-inflammatory natural killer T lymphocyte function in pathogenic simian immunodeficiency virus infection.

by Namita Rout, Justin Greene, Simon Yue, David O'Connor, R Paul Johnson, James G Else, Mark A Exley, Amitinder Kaur
Published 2012-09-01